9EM-33776-23905
4 vaccinations
4 coded responses
44 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 554 / MN
- Registered
- 2021-01-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Registered in v-safe
-
2021-01-15
Dose 1 — Moderna
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-22
-
2021-01-29
Survey response — day 14, dose 1MedDRA: Eczema — Feeling: GoodFree text: EczemaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-05
-
2021-02-12
Dose 2 — Moderna
-
2021-02-12
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
-
2021-02-26
Survey response — day 14, dose 2MedDRA: Pre-existing disease — Feeling: GoodFree text: EczemaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-05
-
2021-03-12
Survey response — day 28, dose 2MedDRA: Eczema — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: EczemaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-12
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-19
- 2021-03-26
- 2021-05-14
- 2021-08-13
-
2021-10-24
Dose 3 — Moderna
-
2021-10-25
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-26
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2021-10-27
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2021-10-28
- 2021-10-29
- 2021-10-30
- 2021-10-31
- 2021-11-07
- 2021-11-14
- 2021-11-23
- 2021-11-28
- 2021-12-05
-
2021-12-21
Call successfulParticipant prefers to complete VAERS report online
- 2022-01-23
- 2022-04-24
-
2022-10-05
Dose 4 — Pfizer-BioNTech
- 2022-10-24
- 2022-10-26
- 2022-11-02
- 2022-11-09
- 2022-11-16
-
2023-01-04
Survey response — 3 months, dose 4MedDRA: Nausea, Vomiting — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-04-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Moderna | |
| 2 | 2021-02-12 | Moderna | |
| 3 | 2021-10-24 | Moderna | No |
| 4 | 2022-10-05 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 3 — day 14, dose 1
Symptoms: Eczema
Release 4 — day 14, dose 2
Symptoms: Eczema
Release 5 — day 28, dose 2
Symptoms: Eczema
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Eczema | ✓ | ✓ | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release